1. Home
  2. CTKB vs CYH Comparison

CTKB vs CYH Comparison

Compare CTKB & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTKB
  • CYH
  • Stock Information
  • Founded
  • CTKB 1990
  • CYH 1985
  • Country
  • CTKB United States
  • CYH United States
  • Employees
  • CTKB N/A
  • CYH N/A
  • Industry
  • CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CYH Hospital/Nursing Management
  • Sector
  • CTKB Health Care
  • CYH Health Care
  • Exchange
  • CTKB Nasdaq
  • CYH Nasdaq
  • Market Cap
  • CTKB 708.8M
  • CYH 623.8M
  • IPO Year
  • CTKB 2021
  • CYH 1991
  • Fundamental
  • Price
  • CTKB $6.27
  • CYH $3.15
  • Analyst Decision
  • CTKB Strong Buy
  • CYH Hold
  • Analyst Count
  • CTKB 3
  • CYH 6
  • Target Price
  • CTKB $9.17
  • CYH $4.70
  • AVG Volume (30 Days)
  • CTKB 646.8K
  • CYH 4.0M
  • Earning Date
  • CTKB 11-05-2024
  • CYH 10-23-2024
  • Dividend Yield
  • CTKB N/A
  • CYH N/A
  • EPS Growth
  • CTKB N/A
  • CYH N/A
  • EPS
  • CTKB N/A
  • CYH N/A
  • Revenue
  • CTKB $201,210,000.00
  • CYH $12,551,000,000.00
  • Revenue This Year
  • CTKB $8.18
  • CYH $1.16
  • Revenue Next Year
  • CTKB $13.21
  • CYH $1.18
  • P/E Ratio
  • CTKB N/A
  • CYH N/A
  • Revenue Growth
  • CTKB 9.88
  • CYH 0.81
  • 52 Week Low
  • CTKB $4.66
  • CYH $2.51
  • 52 Week High
  • CTKB $9.87
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • CTKB 45.80
  • CYH 32.04
  • Support Level
  • CTKB $6.11
  • CYH $3.32
  • Resistance Level
  • CTKB $6.78
  • CYH $3.53
  • Average True Range (ATR)
  • CTKB 0.33
  • CYH 0.18
  • MACD
  • CTKB -0.09
  • CYH 0.00
  • Stochastic Oscillator
  • CTKB 13.95
  • CYH 15.28

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: